News

New panels for diagnosing hereditary cancer 

Published on April 25, 2017

We are now providing a more targeted panel for high risk breast cancer diagnostics. The Hereditary Breast Cancer High Risk Panel analyzes seven genes associated with inherited susceptibility to breast cancer. We have also added a new 27-gene panel to our test menu for diagnosing inherited susceptibility to breast and gynecological cancer.

Read more

We’re hiring a ABMG certified Geneticist to join our Clinical Operation Team

Published on April 3, 2017

We seek a highly motivated individual who can utilize their superior clinical and technical skills in providing state-of-the-art clinical test reports and genetic diagnostic service. We are looking for highly motivated individuals who demonstrate effort and initiative; team players who are willing to accept personal accountability for successful job performance…

Read more

Blueprint receives the BioFinland Award 2017

Published on March 29, 2017

We are very proud and thankful to receive the BioFinland Award 2017, today on March 29th. This is a great recognition to the whole team that constantly works to bring genetic testing of inherited disorders into mainstream healthcare, cost efficiently without ever compromising quality. The awards is presented by the Finnish Bioindustries…

Read more

New Face2Gene case report to help phenotype patients

Published on March 27, 2017

FDNA provides a HIPAA-compliant Face2Gene deep learning technology that de-identifies and analyzes cases to identify new phenotypes, facial characteristics and genes that are associated with rare diseases. The new Face2Gene case report enables a clinician to share their patient’s case phenotype with Blueprint Genetics to help improve variant filtering and…

Read more

Foundation Fighting Blindness and Blueprint Genetics Announce Collaboration to Support Genetic Testing and Patient Registry Process for IRD Patients

Published on March 21, 2017

(Columbia, Maryland) – The Foundation Fighting Blindness (FFB), the world’s leading private funder of research for cures for inherited retinal diseases and Blueprint Genetics today announced a collaborative research study to  grow the data in a Foundation-supported patient registry for inherited retinal diseases (IRDs), called “My Retina Tracker”, and,…

Read more

Blueprint Genetics on valittu vuoden 2017 Kasvunrakentajaksi

Published on March 17, 2017

Vuoden 2017 Kasvunrakentaja on Blueprint Genetics. Suomen pääomasijoitusyhdistys – FVCA:n ja PwC:n yhteistyössä järjestämän Kasvunrakentaja 2017 -kilpailun finaalissa etsittiin pääomasijoittajien yli 700 kohdeyhtiön joukosta mielenkiintoisinta ja innostavinta tarinaa. Suomen pääomasijoitusyhdistyksen ja PwC:n Kasvunrakentaja 2017 -kilpailun voittajaksi valittiin Blueprint Genetics, jonka geenitestausteknologia auttaa löytämään harvinaisia perinnöllisiä tauteja.

Read more

We’re hiring Software Engineers to join our Informatics Team

Published on March 17, 2017

Blueprint Genetics is a Next-Generation Sequencing (NGS) company based in Helsinki, Finland. We are a team of more than 50+ professionals running an accredited clinical laboratory providing genetic diagnostics for professional clinical use. Our current diagnostic portfolio includes over 400 tests that cover rare hereditary disorders in 14 medical specialties.

Read more

Product/Support Specialist

Published on March 15, 2017

We are looking for an intelligent, organized, creative, social and proactive person to fill our Support Team position. An ideal candidate has knowledge in medical genetics and experience in customer service or customer support. Fluent English and Finnish skills are a must. Ability to communicate with customers in other languages…

Read more

Geneticist

Published on March 15, 2017

We offer challenging work in an innovative, dynamic and motivated team of physicians, geneticists, bioinformaticians and molecular biologists. The position involves interpretation and reporting of clinical molecular genetic test results. Duties also include development and validation of tests and applications in a project team environment. An ideal candidate has experience…

Read more

Blueprint Genetics joins FDNA’s Year of Discovery, uniting clinicians globally with deep learning technology to make rare disease discoveries

Published on February 27, 2017

We are inviting clinicians worldwide to participate in FDNA’s Year of Discovery. Clinicians are invited to submit patient photos, diagnoses, and phenotypes to the HIPAA-compliant Face2Gene CLINIC system for analysis. March is the month for RASopathies. Blueprint will match each RASopathy case uploaded during the month with a $1 donation…

Read more

Comprehensive panel based approach to clinical genetics, with over 200 panels covering 14 medically relevant specialties

Published on February 23, 2017

We are on a mission to challenge the standards of clinical genetic diagnostics to enable better patient care. Over the last 5 years we have developed unique sequencing technologies, in-house bioinformatics and interpretation solutions to improve rare disease genetic diagnostics. Without compromising quality and performance, our innovations are enabling more affordable…

Read more

Blueprint Genetics listed as one of the hottest start-up companies in Finland!

Published on February 21, 2017

The Jury of Talouslämä, a Finnish weekly business magazine listed the top ten hottest start-up companies in Finland. The selection was made among hundreds of companies. We are delighted to be on the list for the third year in a row!   Read the whole article: http://www.talouselama.fi/lehti/talouselama-kokosi-suomen-10-kuuminta-startup-yhtiota-tassa-ne-ovat-6625765   Talouselämä 6/2017, published…

Read more

New address for Blueprint Genetics San Francisco from Febuary 14, 2017

Published on February 7, 2017

Blueprint Genetics San Francisco office moves to a new address. Starting on February 14, 2017, our new address is:   1250 Missouri Street, #208 San Francisco, CA 94107   All correspondence, billing and samples for countries in North and South America should be directed here. If you have any questions…

Read more

Enjoy the holiday season and happy new year 2017!

Published on December 22, 2016

A year ago we wrote that “2015 was great for genetic diagnostics but 2016 will be even better”. Today, we are happy to say that the past year has fulfilled our expectations. As a new year is dawning, it is once again time to thank all of our…

Read more

Blueprint Genetics on Kauppalehti Optio – an article about the life science and health technology innovations in Finland

Published on November 24, 2016

Article about the life science and health technology innovations and the growth of the healthcare industry in Finland on Kauppalehti Optio, a Finnish business magazine. To read the whole article (available in Finnish only), click here.   Blueprint Genetics yhdessä muiden life science ja terveysalanyritysten kanssa viemässä huipputason terveysteknologiaa…

Read more

High-quality whole exome sequencing products now available

Published on November 24, 2016

Targeted high coverage deep sequencing of clinically relevant genes forms the basis of rare disease diagnostics for most patients. In clinical practice, however, we meet cases where the clinical phenotype is novel or complex and an optimal panel diagnostic strategy cannot be established. For these cases, Blueprint Genetics is now offering…

Read more

Media contact

Juulia Simonen

Communication manager

+358 50 305 9018

juulia.simonen@blueprintgenetics.com

Subscribe to our releases

Get our latest press releases.